Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Healthcare Biotechnology
Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency... see more

Recent & Breaking News (TSX:MBX)

Microbix Presenting STI Multiplex Test Controls at AACC

GlobeNewswire July 26, 2022

Microbix Presenting Test Validation Methods at AACC

GlobeNewswire June 3, 2022

Microbix Reports Record Results for Q2 Fiscal 2022

GlobeNewswire May 12, 2022

Microbix Presenting Omicron Test Control Results at CVS

GlobeNewswire April 29, 2022

Microbix Presenting at the 2022 Bloom Burton Conference

GlobeNewswire April 28, 2022

Microbix Presenting Respiratory Virus Controls Data at Two Events

GlobeNewswire April 19, 2022

Microbix Presenting HPV Product Results at EUROGIN

GlobeNewswire April 8, 2022

Microbix Announces Annual and Special Meeting Voting Results

GlobeNewswire March 31, 2022

Microbix Invests to Further Scale Its Business

GlobeNewswire March 29, 2022

Microbix Announces Issuance of Stock Options

GlobeNewswire February 24, 2022

Microbix Announces Nomination to Board of Directors

GlobeNewswire February 22, 2022

Microbix Presenting at Capital Conference in B.C.

GlobeNewswire February 17, 2022

Microbix Advances Commissioning of Sites Two and Three

GlobeNewswire February 15, 2022

Microbix Reports Record Results for Q1 Fiscal 2022

GlobeNewswire February 10, 2022

Microbix Launches Omicron Variant Test Control

GlobeNewswire February 1, 2022

Microbix (TSX:MBX) receives $4.7M order

Trevor Abes  December 24, 2021

Microbix Receives $4.7 Million Order for Viral Transport Medium

GlobeNewswire December 24, 2021

Microbix (TSX:MBX) reports record results for 2021

Julia Kennedy  December 23, 2021

Microbix Reports Record Results for Fiscal 2021

GlobeNewswire December 23, 2021

Microbix Launches Multiplex Respiratory PCR-Test Control

GlobeNewswire December 20, 2021